Navigation Links
InterMune to Release Third Quarter Financial Results on November 5
Date:10/29/2009

BRISBANE, Calif., Oct. 29 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) announced today that it will release third quarter 2009 financial results on Thursday, November 5, 2009 at 4:00 p.m. Eastern time. A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day.

To access the live teleconference, dial 888-799-0528 (U.S.) or 973-200-3372 (international), conference ID# 37626791. To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

A replay of the webcast and teleconference will be available approximately three hours after the call. The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 37626791.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes pirfenidone for which a Phase 3 program in patients with IPF (CAPACITY) has been completed and the compound is currently in the pre-registration stage. The company also has a research program focused on a pirfenidone analog named ITMN-520. The hepatology portfolio includes the HCV protease inhibitor compound RG7227 (ITMN-191) that entered Phase 2b in August of 2009 and a second-generation HCV protease inhibitor research program. For additional information about InterMune and its R&D pipeline,
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
2. InterMune to Present at Canaccord Adams Conference
3. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
4. InterMune to Release Second Quarter Financial Results on August 6
5. InterMune to Present at Goldman Sachs Healthcare Conference
6. InterMune Reports First Quarter 2009 Financial Results and Business Highlights
7. InterMune to Release First Quarter Financial Results on April 30
8. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
9. InterMune to Present at Canaccord Adams Hepatitis C Conference
10. InterMune to Present at Citis 4th Annual Biotech Day
11. InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Dr. Williams says, “Bush has joined the ... the greatest health care system in the world is ... while trying to serve the public. Unfortunately, Bush has ... an enormous system that none of them can first ... series of Open Letters ( http://is.gd/wdU2CM ) provides a ...
(Date:7/21/2014)... July 21, 2014 With a ... programming, the new Cole-Parmer® Digital Gear Pump ... easy to operate for automated process applications. , ... dispensing. The batch count function counts down and ... totalizer tracks amount dispensed across multiple cycles. View ...
(Date:7/21/2014)... chemist in Syracuse University,s College of Arts and ... the synthesis of stainless nanoparticles. , Mathew M. ... a three-year, $360,000 grant from the National Science ... with metal stainless alloy nanostructures, the results of ... rechargeable lithium-ion batteries. , Maye,s approach ...
(Date:7/21/2014)... PHILADELPHIA , July 21, 2014  Mike ... closing of $1.6 million in Series Seed B ... and chemical sensors for the life science, defense, ... Trimaran Capital Partners led the round and was ... 36 Angels.  Said Patterson , "This round ...
Breaking Biology Technology:Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2New Easy-View Cole-Parmer Digital Gear Pump Drive Makes Performance Monitoring Effortless 2Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology 2
... Jan. 30 Monogram,Biosciences, Inc., (Nasdaq: MGRM ) ... February 7, 2008 at 4:30 p.m. (Eastern Time) to ... outlook for 2008.,The call will be hosted by Mr. ... participate in the live teleconference, please call (877) 545-1409,or ...
... Helix BioPharma Corp. (TSX: HBP / Frankfurt: WKN ... Helix BioPharma Corp.,announces that at the Company,s Annual ... all of the resolutions presented by,management, appointing KPMG ... Cawkell, Jack Kay, Slawomir Majewski, and Gordon Lickrish ...
... 30 In a letter to,Governor Jennifer Granholm ... the Governor,s State of the State Address,wherein she ... MichBio is the,statewide association for Michigan,s life sciences ... of the legislature, to diversify,the state,s economy by ...
Cached Biology Technology:Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call 2Helix BioPharma shareholders vote in favour of management 2MichBio Responds to Governor's Plan to Repeal Tort Reform Laws 2
(Date:7/22/2014)... promise for treating damaged organs and tissues, but with ... their effectiveness. New methods are being developed and tested ... after transplantation, as described in a Review article in ... Mary Ann Liebert, Inc., publishers. The article is available ... website . , In the article ,Preconditioning ...
(Date:7/22/2014)... Cambridge, MA and Shenzhen, China July 22, ... Tech), a subsidiary of BGI, the world,s largest ... a new human whole exome sequencing service based ... service includes in-depth bioinformatics analysis and SNP validation, ... 31, 2014. , Complete Genomics, highly regarded ...
(Date:7/22/2014)... a place emerging as a world-famous vacation spot with natural ... on the island. The Korea Institute of Geoscience and Mineral ... that a recent volcanic eruption was evident 5,000 years ago. ... date when lava spewed out of a volcano 5,000 years ... as the one the whole peninsula. , The research team ...
Breaking Biology News(10 mins):BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2Jeju Island is a live volcano 2
... case state-of-the-art energy efficient housing will be officially opened ... Nottingham. The house built by BASF, a major ... part of the Creative Energy Homes Project on University ... of Built Environment to stimulate sustainable design ideas and ...
... Heritage Foundation (CHF) announced that Leroy Hood ... Award. Jointly sponsored by the Pittsburgh Conference ... and CHF, this award recognizes outstanding individuals ... community, inspired achievement, promoted public understanding of ...
... Ala. The long-sought-after biological gateway that anthrax uses ... at the University of Alabama at Birmingham (UAB). ... a receptor that sits on the surface of certain ... exactly how the bacteria get inside cells to begin ...
Cached Biology News:Opening day for a home of the future 2Opening day for a home of the future 3Leroy Hood to receive 2008 Pittcon Heritage Award 2Leroy Hood to receive 2008 Pittcon Heritage Award 3Anthrax cellular entry point uncovered 2
...
Mynox is intended for research use only. Mynox is used for the elimination of Mycoplasma and Acholeplasma in cell and virus cultures, and other biologicals....
... Acridinium NHS ester can be ... nucleic acids. The covalently bound ... chemiluminescence in the presence of ... proteins can be used as ...
... The electrophoretic mobility shift assay (EMSA) is ... Often referred to as gel shift or ... the principle that when subjected to electrophoresis, ... DNA-protein complex. The Pierce LightShift Chemiluminescent EMSA ...
Biology Products: